Management of metastatic testicular germ cell tumors

Pernelle Lavaud; Giulia Baciarello; Karim Fizazi

doi:10.1016/j.bulcan.2019.05.004

Management of metastatic testicular germ cell tumors

Pernelle Lavaud, Giulia Baciarello, Karim Fizazi

Research output: Contribution to journal › Review article › peer-review

Abstract

Metastatic testicular germ cell tumors are rare entities with a high cure rate owing to their major chemosensitivity. Current guidelines should be strictly followed to ensure maximal cure rate. Germ cell tumor treatment requires multidisciplinary skills and is based on cisplatin-based chemotherapy. The current challenge for these patients with favorable prognosis is to limit over- or under-treatment. Centralization of care for patients with these rare cancers is a key point to achieve the best chance of cure.

Translated title of the contribution	Principes de prise en charge des tumeurs germinales testiculaires métastatiques
Original language	English
Pages (from-to)	896-902
Number of pages	7
Journal	Bulletin du Cancer
Volume	106
Issue number	10
DOIs	https://doi.org/10.1016/j.bulcan.2019.05.004
Publication status	Published - 1 Oct 2019

Keywords

Follow-up
Metastases
Testicular germ cell cancer
Treatment

Access to Document

10.1016/j.bulcan.2019.05.004

Cite this

@article{2e933525ce014ecc81a315ed10c6c72c,

title = "Management of metastatic testicular germ cell tumors",

abstract = "Metastatic testicular germ cell tumors are rare entities with a high cure rate owing to their major chemosensitivity. Current guidelines should be strictly followed to ensure maximal cure rate. Germ cell tumor treatment requires multidisciplinary skills and is based on cisplatin-based chemotherapy. The current challenge for these patients with favorable prognosis is to limit over- or under-treatment. Centralization of care for patients with these rare cancers is a key point to achieve the best chance of cure.",

keywords = "Follow-up, Metastases, Testicular germ cell cancer, Treatment",

author = "Pernelle Lavaud and Giulia Baciarello and Karim Fizazi",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.bulcan.2019.05.004",

language = "English",

volume = "106",

pages = "896--902",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "10",

}

TY - JOUR

T1 - Management of metastatic testicular germ cell tumors

AU - Lavaud, Pernelle

AU - Baciarello, Giulia

AU - Fizazi, Karim

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Metastatic testicular germ cell tumors are rare entities with a high cure rate owing to their major chemosensitivity. Current guidelines should be strictly followed to ensure maximal cure rate. Germ cell tumor treatment requires multidisciplinary skills and is based on cisplatin-based chemotherapy. The current challenge for these patients with favorable prognosis is to limit over- or under-treatment. Centralization of care for patients with these rare cancers is a key point to achieve the best chance of cure.

AB - Metastatic testicular germ cell tumors are rare entities with a high cure rate owing to their major chemosensitivity. Current guidelines should be strictly followed to ensure maximal cure rate. Germ cell tumor treatment requires multidisciplinary skills and is based on cisplatin-based chemotherapy. The current challenge for these patients with favorable prognosis is to limit over- or under-treatment. Centralization of care for patients with these rare cancers is a key point to achieve the best chance of cure.

KW - Follow-up

KW - Metastases

KW - Testicular germ cell cancer

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85071091007&partnerID=8YFLogxK

U2 - 10.1016/j.bulcan.2019.05.004

DO - 10.1016/j.bulcan.2019.05.004

M3 - Review article

C2 - 31466695

AN - SCOPUS:85071091007

SN - 0007-4551

VL - 106

SP - 896

EP - 902

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 10

ER -

Management of metastatic testicular germ cell tumors

Abstract

Keywords

Access to Document

Other files and links

Cite this